Literature DB >> 6501268

Stage-specific polypeptides in the developing mouse brain as demonstrated by two-dimensional gel electrophoresis.

S Noguchi, S Ogata, M Sato, T Muramatsu.   

Abstract

Protein alterations during the development of the mouse brain were studied by two-dimensional gel electrophoresis. A protein spot with a molecular weight (MW) of 68,000 and pI value of 5.6 was found in the brain of the 11th day of gestation. Between the 12th and the 14th day of gestation, spots with the same MW and lower pI values appeared progressively. Neuraminidase digestion converted the pI of these acidic spots to 5.6. Thus, increased sialylation appeared to occur during this period. This class of molecules became hardly detectable on the 15th day, and disappeared completely after the 16th day. Analogous spots were present in the heart, liver, and stomach of the embryos, although the increased sialylation was not observed in the liver. No adult organs so far examined showed these spots. On the other hand, two polypeptides (MW 55,000, pI 4.7, and 53,000, pI 4.6) appeared in the brain on the 13th day of gestation and persisted throughout the fetal period. After birth, they became hardly detectable. Furthermore, a spot (MW 48,000, pI 4.8) became newly detectable in the brain 4-5 weeks after the birth.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6501268     DOI: 10.1093/oxfordjournals.jbchem.a134906

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  2 in total

1.  Radioactive labeling of proteins in cultured postimplantation mouse embryos. I. Influence of the embryo preparation method.

Authors:  J Nowak; J Klose
Journal:  In Vitro Cell Dev Biol       Date:  1989-07

2.  Radioimmunoimaging of tumors with radioactive antibody against a glycoprotein (GP68) found in developing mouse brain.

Authors:  S Kojima; A Awaya; M Ishido; Y Koyama; A Kubodera; Y Hashimoto; H Fukui; H Muramatsu; T Muramatsu
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.